APA

Mitterbauer G., Nemeth P., Wacha S., Cross N. C., Schwarzinger I., Jaeger U., Geissler K., Greinix H. T., Kalhs P., Lechner K. & Mannhalter C. (19991026). Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction. : British journal of haematology.

Chicago

Mitterbauer G, Nemeth P, Wacha S, Cross N C, Schwarzinger I, Jaeger U, Geissler K, Greinix H T, Kalhs P, Lechner K and Mannhalter C. 19991026. Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction. : British journal of haematology.

Harvard

Mitterbauer G., Nemeth P., Wacha S., Cross N. C., Schwarzinger I., Jaeger U., Geissler K., Greinix H. T., Kalhs P., Lechner K. and Mannhalter C. (19991026). Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction. : British journal of haematology.

MLA

Mitterbauer G, Nemeth P, Wacha S, Cross N C, Schwarzinger I, Jaeger U, Geissler K, Greinix H T, Kalhs P, Lechner K and Mannhalter C. Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction. : British journal of haematology. 19991026.